BIO-Europe 2026 to Convene in Cologne This November
Over 6,000 senior biopharma executives will gather in Germany for the 32nd annual edition of the major partnering conference.
Updated on Oct. 27, 2026 in Biotech
Live Poll
Do you trust pharmaceutical companies to prioritize affordable patient access over their own business models?
BIO-Europe 2026 will convene in Cologne, Germany, from November 9-11, 2026, to host more than 6,000 senior biopharma industry leaders. The 32nd edition of the event will feature the inaugural results of the Biopharma C-Suite Agenda Survey 2026.
Why it matters
The conference serves as a critical hub for addressing industry-wide challenges in financing, clinical development, and strategic partnerships. It provides a dedicated venue for leaders to navigate the evolving landscape of global biopharma operations.
The conference will host over 6,000 senior executives to facilitate one-to-one partnering via the partneringONE platform. The 2026 survey includes data from 81 senior executives, with 50 CEOs contributing to the findings.
The players
BIO-Europe
This is a premier annual biopharma partnering conference that facilitates strategic collaboration between global pharmaceutical and biotechnology leaders.
partneringONE
This is a specialized digital platform designed to manage one-to-one meetings and networking for attendees at international life sciences conferences.
The details
Participants will engage in high-level strategic discussions while utilizing the partneringONE system for professional networking and deal-making. A Digital Partnering Pass is available for those seeking virtual access to sessions and on-demand content.
Timeline
November 9-11, 2026: BIO-Europe 2026 conference convenes in Cologne.
November 17-18, 2026: Virtual partnering days occur for Digital Partnering Pass holders.
The Tech Race
As the 32nd edition of the BIO-Europe event, this gathering reflects the ongoing evolution of biopharma networking and the transition toward integrated digital-physical deal-making. It highlights the shift away from legacy trade shows toward data-driven, strategic partnering ecosystems.
Attendees can leverage the conference to accelerate their professional networking through one-to-one meetings facilitated by the partneringONE platform. Virtual participants gain access to the same on-demand content and collaborative sessions via the Digital Partnering Pass.
The takeaway
The high percentage of executives predicting increased M&A activity suggests a period of significant corporate consolidation is on the horizon. Leaders attending the event should focus on identifying potential partners that align with these shifting capital appetites.
Further reading
For more on industry developments, visit the Biotech section.
More information
For registration details, visit the BIO-Europe event registration and information page.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust pharmaceutical companies to prioritize affordable patient access over their own business models?
